Bill Sponsor
Senate Bill 3336
117th Congress(2021-2022)
HALT Fentanyl Act
Introduced
Introduced
Introduced in Senate on Dec 8, 2021
Overview
Text
Introduced
Dec 8, 2021
Latest Action
Dec 8, 2021
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
3336
Congress
117
Policy Area
Crime and Law Enforcement
Crime and Law Enforcement
Primary focus of measure is criminal offenses, investigation and prosecution, procedure and sentencing; corrections and imprisonment; juvenile crime; law enforcement administration. Measures concerning terrorism may fall under Emergency Management or International Affairs policy areas.
Sponsorship by Party
Republican
Louisiana
Republican
North Carolina
Senate Votes (0)
House Votes (0)
No Senate votes have been held for this bill.
Summary

Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act

This bill places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration.

The bill also makes several other changes to registration requirements for conducting research with controlled substances, including

  • permitting a single registration for related research sites in certain circumstances,
  • waiving the requirement for a new inspection in certain situations, and
  • allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.
Text (1)
December 8, 2021
Actions (2)
12/08/2021
Read twice and referred to the Committee on the Judiciary.
12/08/2021
Introduced in Senate
Public Record
Record Updated
Feb 23, 2023 3:23:24 PM